Impact of the FDA Antidepressant Black Box Warning on the Quality of Psychiatric Practice. Inclusive Dates: 03/01/07 - 10/31/09.

摘要

The study examined the policy impact of the Food and Drug Administration (FDA) antidepressant black box warning on the utilizations of psychotropic medications and psychiatric services among children and adolescents with and without a diagnosis of depression.